Media call 11 am, Garvan Institute with researchers and the late Rebecca Wilson’s brother, Jim Wilson Meet in the foyer of the Kinghorn Cancer Centre, 370 Victoria St, Darlinghurst NSW 2010 Images Footage Researchers are recruiting volunteers for a clinical trial they hope will improve survival rates for an aggressive form of breast cancer that…

Australian researchers uncover hidden genetic markers of glaucoma. Stem cell models of the retina and optical nerve have been used to identify previously unknown genetic markers of glaucoma, in research jointly led by scientists from the Garvan Institute of Medical Research, the University of Melbourne, and the Centre for Eye Research Australia. The findings open…

Most autoimmune diseases are easy to diagnose but hard to treat. A paper published in Science proposes using your unique immune cell fingerprint to rapidly identify which treatments will work for your autoimmune disease. ‘We analysed the genomic profile of over one million cells from 1,000 people to identify a fingerprint linking genetic markers to…

A private public partnership to strengthen Australia’s position at the forefront of the cancer treatment revolution. The Precision Oncology Screening Platform Enabling Clinical Trials (PrOSPeCT) will establish Australia is a medical manufacturing hub: building links from research through to the clinic; creating jobs; changing lives. Announced by the Australian Government at the Garvan Institute of…

Images and media kit download A single DNA test has been developed that can screen a patient’s genome for over 50 genetic neurological and neuromuscular diseases such as Huntington’s disease, muscular dystrophies and fragile X syndrome. The new test avoids a ‘diagnostic odyssey’ for patients that can take decades. The team, from Australia, UK and…